Your browser doesn't support javascript.
loading
Early acute kidney injury after liver transplantation: Predisposing factors and clinical implications.
Rahman, Suehana; Davidson, Brian R; Mallett, Susan V.
Afiliación
  • Rahman S; Suehana Rahman, Susan V Mallett, Royal Free Perioperative Research Group, Department of Anaesthesia, Royal Free Hospital, Royal Free NHS Foundation Trust, London NW3 2QG, United Kingdom.
  • Davidson BR; Suehana Rahman, Susan V Mallett, Royal Free Perioperative Research Group, Department of Anaesthesia, Royal Free Hospital, Royal Free NHS Foundation Trust, London NW3 2QG, United Kingdom.
  • Mallett SV; Suehana Rahman, Susan V Mallett, Royal Free Perioperative Research Group, Department of Anaesthesia, Royal Free Hospital, Royal Free NHS Foundation Trust, London NW3 2QG, United Kingdom.
World J Hepatol ; 9(18): 823-832, 2017 Jun 28.
Article en En | MEDLINE | ID: mdl-28706581
ABSTRACT

AIM:

To investigate the additional clinical impact of hepatic ischaemia reperfusion injury (HIRI) on patients sustaining acute kidney injury (AKI) following liver transplantation.

METHODS:

This was a single-centre retrospective study of consecutive adult patients undergoing orthotopic liver transplantation (OLT) between January 2013 and June 2014. Early AKI was identified by measuring serum creatinine at 24 h post OLT (> 1.5 × baseline) or by the use of continuous veno-venous haemofiltration (CVVHF) during the early post-operative period. Patients with and without AKI were compared to identify risk factors associated with this complication. Peak serum aspartate aminotransferase (AST) within 24 h post-OLT was used as a surrogate marker for HIRI and severity was classified as minor (< 1000 IU/L), moderate (1000-5000 IU/L) or severe (> 5000 IU/L). The impact on time to extubation, intensive care length of stay, incidence of chronic renal failure and 90-d mortality were examined firstly for each of the two complications (AKI and HIRI) alone and then as a combined outcome.

RESULTS:

Out of the 116 patients included in the study, 50% developed AKI, 24% required CVVHF and 70% sustained moderate or severe HIRI. Median peak AST levels were 1248 IU/L and 2059 IU/L in the No AKI and AKI groups respectively (P = 0.0003). Furthermore, peak serum AST was the only consistent predictor of AKI on multivariate analysis P = 0.02. AKI and HIRI were individually associated with a longer time to extubation, increased length of intensive care unit stay and reduced survival. However, the patients who sustained both AKI and moderate or severe HIRI had a longer median time to extubation (P < 0.001) and intensive care length of stay (P = 0.001) than those with either complication alone. Ninety-day survival in the group sustaining both AKI and moderate or severe HIRI was 89%, compared to 100% in the groups with either or neither complication (P = 0.049).

CONCLUSION:

HIRI has an important role in the development of AKI post-OLT and has a negative impact on patient outcomes, especially when occurring alongside AKI.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: World J Hepatol Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: World J Hepatol Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido